Meeting to be held in Boston on March 27 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HRMY:
- Harmony Biosciences management to meet with Oppenheimer
- Harmony Biosciences price target lowered to $40 from $42 at Mizuho
- Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- Harmony Biosciences Releases Investor Presentation Update
- Harmony Biosciences reports Q4 adjusted EPS 73c, consensus 48c